Literature DB >> 10981151

Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways.

K D Lake-Bruse1, C D Sigmund.   

Abstract

Essential hypertension is an insidious disease in which the afflicted person risks disability and death from myocardial infarction and stroke. Many factors contribute to the development of essential hypertension, including environment, diet, daily stress, and genetics. Although several single gene disorders causing high blood pressure have been identified, the genetics of essential hypertension are much more complicated. The current hypothesis is that a combination of genetic variations in multiple genes may predispose a person to hypertension. Both overexpression and gene inactivation ("knockout") have proven useful tools to evaluate the genetics of essential hypertension and to identify pathways regulating blood pressure. Molecular and physiologic evaluations of transgenic and knockout mice carried out over the past 5 years have provided a plethora of information about the mechanisms of blood pressure regulation and the development and maintenance of hypertension. This review focuses on the newer mouse models that have been developed to investigate hypertension with an emphasis on vascular and renal mechanisms, contributed by the renin-angiotensin system, and other pathways intersecting with the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981151     DOI: 10.1007/s11906-000-0084-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  48 in total

1.  Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

Authors:  X P Yang; Y H Liu; E G Shesely; M Bulagannawar; F Liu; O A Carretero
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

2.  Homeostasis in mice with genetically decreased angiotensinogen is primarily by an increased number of renin-producing cells.

Authors:  H S Kim; N Maeda; G T Oh; L G Fernandez; R A Gomez; O Smithies
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

3.  Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet.

Authors:  P Harding; D H Sigmon; M E Alfie; P L Huang; M C Fishman; W H Beierwaltes; O A Carretero
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

Review 4.  Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.

Authors:  B C Kone; C Baylis
Journal:  Am J Physiol       Date:  1997-05

5.  Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.

Authors:  H M Siragy; T Inagami; T Ichiki; R M Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice.

Authors:  H Ling; C Edelstein; P Gengaro; X Meng; S Lucia; M Knotek; A Wangsiripaisan; Y Shi; R Schrier
Journal:  Am J Physiol       Date:  1999-09

7.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

Authors:  J E Dinchuk; B D Car; R J Focht; J J Johnston; B D Jaffee; M B Covington; N R Contel; V M Eng; R J Collins; P M Czerniak
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

10.  Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion.

Authors:  S Saitoh; A G Scicli; E Peterson; O A Carretero
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

View more
  2 in total

1.  A genetically clamped renin transgene for the induction of hypertension.

Authors:  Kathleen M I Caron; Leighton R James; Hyung-Suk Kim; Scott G Morham; Maria Luisa S Sequeira Lopez; R Ariel Gomez; Timothy L Reudelhuber; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.